SCHEMBL6627397

SCHEMBL6627397

CC(C)(C)OC(=O)Nc1cnccc1CCN1CCCC1.Nc1cnccc1CCN1CCCC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.39
BACE1 P56817 1/20 0.39
DRD2 P14416 1/20 0.37
CCNE2 O96020 1/20 0.37
CCNE1 P24864 1/20 0.37
CDK2 P24941 1/20 0.37
GSK3B P49841 1/20 0.37
ABL1 P00519 3/20 0.36
PTK6 Q13882 2/20 0.36
PDE5A O76074 2/20 0.36
PDE4A P27815 2/20 0.36
PDE1A P54750 2/20 0.36
PDE1B Q01064 2/20 0.36
PDE4B Q07343 2/20 0.36
PDE4C Q08493 2/20 0.36
PDE4D Q08499 2/20 0.36
PDE3B Q13370 2/20 0.36
PDE1C Q14123 2/20 0.36
PDE3A Q14432 2/20 0.36
CYP17A1 P05093 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6595468 0.94 ACHE (0.42) ACHEBACE1DRD2CCNE2CCNE1
SCHEMBL6604898 0.88 CCNE2 (0.45) ACHEBACE1CCNE2CCNE1CDK2
SCHEMBL6035419 0.88 ACHE (0.46) ACHEBACE1DRD2CYP17A1
SCHEMBL6595160 0.78 GPR119 (0.34) ACHEBACE1CCNE2CCNE1CDK2
SCHEMBL6034963 0.78 HRH3 (0.54) DRD2
SCHEMBL6035089 0.77 HRH3 (0.45) DRD2CCNE2CCNE1CDK2GSK3B
SCHEMBL12018154 0.75 CYP17A1 (0.48) CYP17A1
SCHEMBL30601022 0.75 CYP17A1 (0.48) CYP17A1
SCHEMBL8209502 0.75 CYP17A1 (0.43) CYP17A1ALDH1A1
SCHEMBL5746021 0.74 NAMPT (0.47) CYP17A1KDM4EALDH1A1GLAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1406877-A1 HETEROCYCLIC AMINES FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH GSK-3 AstraZeneca AB (SE) 2004-04-14 EP disclosed
WO-2003004475-A1 HETEROCYCLIC AMINES FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH GSK-3 ASTRAZENECA AB (SE) 2003-01-16 WO disclosed